MannKind Corporation is an award-winning pharmaceuticals company headquartered in Westlake Village, California, with offices in Dansbury, Connecticut. Focused on its patients and passionate about innovation, the company pays special attention to discovering, developing, and commercializing therapeutic products for individuals with diabetes, pulmonary arterial hypertension, and other diseases.

MannKind Corporation was founded in 1991 as Pharmaceutical Discovery Corporation (PDC) until it merged with companies owned by Alfred Mann in the mid-1990s. MannKind Corporation continued to innovate its flagship Technosphere technology, a drug-delivery platform that allows the pulmonary administration of therapeutics. In addition, the new company developed further delivery devices, and its first product in 2014: Afrezza (insulin human) inhalation powder, offering the only fast-acting, inhaled mealtime insulin in the U.S. MannKind Corporation is proud of its continuing research and development initiatives, which still focus on self-administered and patient-friendly inhalers. Recent technology innovations include a dry-powder formulation and a wireless pressure-sensing technology that communicates information via a smart device. 

MannKind Corporation operates on values of integrity, leadership, teamwork, and communication; principles that guide company actions and serve as cultural cornerstones. The company is committed to diversity and rewarding its close-knit team as its number-one asset. MannKind Corporation promotes wellness and work-life balance with benefits like health insurance, retirement savings plans, paid time off, and flexible work arrangements, such as remote jobs and work-from-home options. Past flexible jobs have been posted in account management, medical & health, and sales for experienced professionals with college degrees.

MannKind Corporation is an award-winning pharmaceuticals company headquartered in Westlake Village, California, with offices in Dansbury, Connecticut. Focused on its patients and passionate about innovation, the company pays special attention to discovering, developing, and commercializing therapeutic products for individuals with diabetes, pulmonary arterial hypertension, and other diseases.

MannKind Corporation was founded in 1991 as Pharmaceutical Discovery Corporation (PDC) until it merged with companies owned by Alfred Mann in the mid-1990s. MannKind Corporation continued to innovate its flagship Technosphere technology, a drug-delivery platform that allows the pulmonary administration of therapeutics. In addition, the new company developed further delivery devices, and its first product in 2014: Afrezza (insulin human) inhalation powder, offering the only fast-acting, inhaled mealtime insulin in the U.S. MannKind Corporation is proud of its continuing research and development initiatives, which still focus on self-administered and patient-friendly inhalers. Recent technology innovations include a dry-powder formulation and a wireless pressure-sensing technology that communicates information via a smart device. 

MannKind Corporation operates on values of integrity, leadership, teamwork, and communication; principles that guide company actions and serve as cultural cornerstones. The company is committed to diversity and rewarding its close-knit team as its number-one asset. MannKind Corporation promotes wellness and work-life balance with benefits like health insurance, retirement savings plans, paid time off, and flexible work arrangements, such as remote jobs and work-from-home options. Past flexible jobs have been posted in account management, medical & health, and sales for experienced professionals with college degrees.